Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 347.45 USD 5.53% Market Closed
Market Cap: 7.6B USD
Have any thoughts about
Madrigal Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast MDGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDGL is 376.24 USD with a low forecast of 156.55 USD and a high forecast of 556.5 USD.

Lowest
Price Target
156.55 USD
55% Downside
Average
Price Target
376.24 USD
8% Upside
Highest
Price Target
556.5 USD
60% Upside

MDGL Last Price Targets
Madrigal Pharmaceuticals Inc

The latest public price target was made on May 29, 2024 by Yasmeen Rahimi from Piper Sandler , who expects MDGL stock to drop by 3% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Yasmeen Rahimi
Piper Sandler
336 USD
Downside 3%
5 months ago
May 29, 2024
Piper Sandler Reiterates Overweight Rating on Madrigal Pharmaceuticals (MDGL)
StreetInsider
Ed Acre
H.C. Wainwright
390 USD
Upside 12%
6 months ago
May 9, 2024
Madrigal Pharmaceuticals (MDGL) PT Lowered to $390 at H.C. Wainwright
StreetInsider
Liisa Bayko
Evercore ISI
405 USD
Upside 17%
8 months ago
Mar 19, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $405 at Evercore ISI, 'well positioned to execute on the launch of Rezdiffra'
StreetInsider
Akash Tewari
Jefferies
400 USD
Upside 15%
8 months ago
Mar 15, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $400 at Jefferies, 'label hit our bull case'
StreetInsider
Eliana Merle
UBS
410 USD
Upside 18%
8 months ago
Mar 15, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $410 at UBS
StreetInsider
Mayank Mamtani
B.Riley Financial
270 USD
Downside 22%
8 months ago
Mar 15, 2024
B.Riley Upgrades Madrigal Pharmaceuticals (MDGL) to Neutral
StreetInsider
Jonathan Wolleben
JMP Securities
397 USD
Upside 14%
8 months ago
Mar 15, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $397 at JMP Securities, ' We had strong conviction'
StreetInsider
Ed Acre
H.C. Wainwright
425 USD
Upside 22%
8 months ago
Mar 15, 2024
Madrigal Pharmaceuticals (MDGL) PT Raised to $425 at H.C. Wainwright, 'Rezdiffra Achieves Landmark Approval'
StreetInsider
Show More Price Targets
Show Less Price Targets
Yasmeen Rahimi
Piper Sandler
Price Target 336 USD
Upside/Downside 3%
View Source
Ed Acre
H.C. Wainwright
Price Target 390 USD
Upside/Downside 12%
View Source
Liisa Bayko
Evercore ISI
Price Target 405 USD
Upside/Downside 17%
View Source
Akash Tewari
Jefferies
Price Target 400 USD
Upside/Downside 15%
View Source
Eliana Merle
UBS
Price Target 410 USD
Upside/Downside 18%
View Source
Mayank Mamtani
B.Riley Financial
Price Target 270 USD
Upside/Downside 22%
View Source
Jonathan Wolleben
JMP Securities
Price Target 397 USD
Upside/Downside 14%
View Source
Ed Acre
H.C. Wainwright
Price Target 425 USD
Upside/Downside 22%
View Source
Show More Price Targets
Show Less Price Targets
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
ZNTL
Zentalis Pharmaceuticals Inc
200% Upside
CSL
CSL Ltd
17% Upside
VYGR
Voyager Therapeutics Inc
211% Upside
AUPH
Aurinia Pharmaceuticals Inc
25% Upside
688739
Liaoning Chengda Biotechnology Co Ltd
53% Upside
RCUS
Arcus Biosciences Inc
136% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
21% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDGL's stock price target?
Price Target
376.24 USD

According to Wall Street analysts, the average 1-year price target for MDGL is 376.24 USD with a low forecast of 156.55 USD and a high forecast of 556.5 USD.

Back to Top